Document is current

Any future updates will be listed below

FREM1 serves as a novel therapeutic target in breast cancer through basement membrane-based prognostic modeling with integrated bioinformatics and experimental validation

Crossref DOI link: https://doi.org/10.1007/s12672-025-04117-3

Published Online: 2025-12-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark